$4.23
0.102.42%
At close: -
$4.25
0.020.47%
After Hours: 8:49 AM EDT
Comments
Loading...
DiaMedica Therapeutics Insider Trading Activity | NASDAQ:DMAC | Benzinga
Track the latest DiaMedica Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for DiaMedica Therapeutics stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are DiaMedica Therapeutics Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
There has been no Insider buying or selling in the last 90 days.
Ownership Statistics for DiaMedica Therapeutics Inc
Shares Outstanding
42.856M
Insider Shares Owned
1.583M
Insider Percentage Owned
3.70%
Institutional Shares Held
2.391M
Institutional Percentage Held
5.58%
| Jul 01, 2024 | Thomas Koch VonAB TomEnterpriseAB Private TomEnterprise | 10% OWNER | 1.20M | $2.50 | $3.00M | BUY | 27.74% | 5.53M | Jun 28 | View |
| Jul 01, 2024 | JAN STAHLBERGAB TRILL | 10% OWNER | 1.20M | $2.50 | $3.00M | BUY | 29.84% | 5.22M | Jun 28 | View |
| Nov 16, 2023 | David Wambeke | CHIEF BUSINESS OFFICER | 20.00K | $2.46 | $49.20K | BUY | 3.94% | 527.11K | Nov 16 | View |
| Jun 27, 2023 | Thomas Koch VonAB TomEnterpriseAB Private TomEqt | 10% OWNER | 1.47M | $3.40 | $5.00M | BUY | 51.49% | 4.33M | Jun 23 | View |
| Jun 26, 2023 | Michael Randall Giuffre | DIRECTOR | 50.00K | $3.91 | $254.15K | BUY | 15.80% | 366.43K | Jun 23 | View |
| Jun 26, 2023 | John Dietrich Pauls | PRESIDENT AND CEO | 12.79K | $3.91 | $50.00K | BUY | 22.91% | 68.59K | Jun 23 | View |
| Jun 26, 2023 | Pauling Charles Semba | DIRECTOR | 12.79K | $3.91 | $50.00K | BUY | 74.53% | 29.94K | Jun 23 | View |
| Jun 26, 2023 | Scott Kellen | CFO AND SECRETARY | 10.00K | $3.91 | $39.10K | BUY | 44.86% | 32.29K | Jun 23 | View |
| Jun 26, 2023 | David Wambeke | CHIEF BUSINESS OFFICER | 38.36K | $3.91 | $150.00K | BUY | 8.18% | 507.11K | Jun 23 | View |
| Jun 26, 2023 | Richard Pilnik | DIRECTOR | 38.36K | $3.91 | $150.00K | BUY | 18.28% | 248.25K | Jun 23 | View |
| Apr 11, 2023 | David Wambeke | CHIEF BUSINESS OFFICER | 468.75K | $1.60 | $750.00K | BUY | ∞ | 468.75K | Apr 10 | View |
| Dec 12, 2022 | Michael Randall Giuffre | DIRECTOR | 57.08K | $1.42 | $81.02K | BUY | 25.46% | 281.30K | Dec 08 - Dec 09 | View |
| Dec 08, 2022 | Michael Randall Giuffre | DIRECTOR | 24.87K | $1.40 | $34.71K | BUY | 12.48% | 224.22K | Dec 06 - Dec 07 | View |
| Dec 06, 2022 | Thomas Koch VonAB TomEnterpriseAB Private TomEqt | 10% OWNER | 0.00 | $1.24 | $0.00 | p / s | 0.00% | 2.86M | Dec 02 | View |
| Dec 05, 2022 | Richard Pilnik | DIRECTOR | 35.00K | $1.39 | $48.49K | BUY | 29.33% | 154.33K | Dec 05 | View |
| Dec 05, 2022 | Michael Randall Giuffre | DIRECTOR | 819.00 | $1.19 | $974.61 | BUY | 0.41% | 199.34K | Dec 01 | View |
| Dec 01, 2022 | Michael Randall Giuffre | DIRECTOR | 67.23K | $1.20 | $80.46K | BUY | 40.89% | 231.64K | Nov 29 - Dec 01 | View |
| Jul 21, 2022 | Thomas Koch VonAB TomEnterprise | 10% OWNER | 207.97K | $1.33 | $275.90K | BUY | 7.85% | 2.86M | Jul 08 | View |
| Sep 15, 2021 | HARRY ALCORN JR | SVP, CLINICAL OPERATIONS | 15.00K | $3.80 | $56.96K | BUY | 51.76% | 43.98K | Sep 15 | View |
| Aug 17, 2021 | Amy Burroughs | DIRECTOR | 44.95K | $3.15 | $141.59K | BUY | ∞ | 44.95K | Aug 16 | View |
| Aug 17, 2021 | Richard Pilnik | DIRECTOR | 15.00K | $3.27 | $49.06K | BUY | 18.62% | 95.56K | Aug 16 | View |
| Aug 16, 2021 | HARRY ALCORN JR | SENIOR VP, CLINICAL OPERATIONS | 20.72K | $3.09 | $64.05K | BUY | ∞ | 399.00 | Aug 16 | View |
| Aug 16, 2021 | John Dietrich Pauls | PRESIDENT AND CEO | 5.00K | $3.14 | $15.70K | BUY | 16.23% | 35.80K | Aug 16 | View |
| Aug 16, 2021 | Scott Kellen | CFO AND SECRETARY | 10.00K | $3.15 | $31.46K | BUY | 81.37% | 22.29K | Aug 16 | View |
| Dec 04, 2020 | Richard Pilnik | — | 10.00K | $5.37 | $53.70K | PURCHASE | 16.43% | 70.85K | Dec 04 | View |
| Nov 23, 2020 | Michael Randall Giuffre | — | 15.00K | $4.26 | $63.91K | PURCHASE | 10.15% | 162.77K | Nov 20 | View |
| Nov 10, 2020 | Scott Kellen | — | 2.00K | $4.19 | $8.39K | PURCHASE | 19.44% | 12.29K | Nov 09 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.
